nebulized tranexamic acid

Phase 3Small molecule

CCairo University

nebulized tranexamic acid is one of 4 small molecule programs targeting Hemoptysis. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

HemoptysisNot yet recruiting

HemoptysisPhase 3

Not yet recruiting

Competition

Competitive Landscape

3 competitors in Hemoptysis

#DrugCompanyPhaseTrials

Adrenaline

SSamson Clinical Operations Pty Ltd

Cyklokapron

4 3

Glypressin

MMallinckrodt

Phase 3

1 4

nebulized tranexamic acid

CCairo University

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

Phase 3Not yet recruiting

Hemoptysis

NCT07641946

Clinical

Trials by Indication[1]

Endoscopic Sinus Surgeries1 trial

Nebulized Versus Intravenous Tranexamic Acid on Surgical Field Quality in Patients Undergoing Endoscopic Sinus Surgeries

Recruiting·—·Phase 4·NCT06777966·60 enrolled

Hemoptysis1 trial

Nebulized Versus Intravenous Tranexamic Acid for the Management of Hemoptysis: A Randomized Controlled Trial

Not yet recruiting·AAssiut University·Phase 3·NCT07641946·170 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for nebulized tranexamic acid. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — nebulized tranexamic acid compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for nebulized tranexamic acid. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Cairo University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: CCairo University

nebulized tranexamic acid

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Trials by Indication[1]

Endoscopic Sinus Surgeries1 trial

Hemoptysis1 trial

References

Drug Info

Quick Facts

Related News